Risk factors associated with trastuzumab-induced cardiotoxicity in patients with human epidermal growth factor receptor 2-positive breast cancer

• Prif Awduron: Wesam Abdel-Razaq (Awdur), Mohammed Alzahrani (Awdur), Majed Al Yami (Awdur), Faisal Almugibl (Awdur), Mohammed Almotham (Awdur), Razan Alregaibah (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Context: Although trastuzumab is a highly effective and selective targeted therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer, the drug-induced cardiotoxicity may confine its usefulness in patients. Aim: To explore risk factors associated with the development of cardi...